Behind the Science: Q & A with Dr. Kathleen Sakamoto

Categories: Researchers
Dr. Kathleen Sakamoto
Funding lifesaving research with Dr. Kathleen Sakamoto We’d like you to meet, Dr. Kathleen Sakamoto, Translational Research Grant recipient.This type of grant funds new research protocols and therapies that hold promise for improved outcomes and accelerates cures from the laboratory bench to the bedside of children and teens with high-risk cancers. Dr. Sakamoto’s hope is …

Read More

Read more »

Behind the Science: Q & A with Dr. Rishi Lulla and Dr. Amanda Saratsis

Categories: Researchers
Dr. Rishi Lulla with Chase
Funding lifesaving research with Dr. Rishi Lulla and Dr. Amanda Saratsis We love to celebrate our researchers every chance we get. Dr. Rishi Lulla and Dr. Amanda Saratsis from Ann & Robert H. Lurie Children’s Hospital of Chicago are changing the future for children fighting cancer. Both recipients of our Translational Research Grant, they are working together …

Read More

Read more »

Behind the Science: Q & A with Dr. Anat Erdreich-Epstein

Categories: Researchers
Dr. Anat Erdreich-Epstein
Meet Dr. Anat Erdreich-Epstein, Translational Research Grant recipient from Children's Hospital Los Angeles. Her focus in this grant is to better understand the biology of medulloblastomas, the most common malignant brain tumors in children, in order to find new ways to approach its treatment.  Read more »

Dr. Kathleen Sakamoto

Categories: Researchers
Lucile Packard Children’s Hospital Stanford University       Dr. Sakamoto sends her most heartfelt and sincerest “thank you” to all the members of the Pediatric Cancer Research Foundation for their dedication and commitment to children with cancer. She has been studying the causes of acute leukemia in children for over 20 years! PCRF is …

Read More

Read more »

Dr. Rodney Miles

Categories: Researchers
University of Utah Non-Hodgkin lymphoma (NHL) is a common cancer in children, adolescents, and young adults. Although curable, a subset of patients still dies because their lymphoma does not respond well to standard therapies. Further research is required to develop novel therapies in the laboratory and then translate these into more effective treatments through clinical …

Read More

Read more »